Your browser doesn't support javascript.
loading
Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study.
Huang, Qiu-Sha; Zhu, Xiao-Lu; Qu, Qing-Yuan; Liu, Xiao; Zhang, Gao-Chao; Su, Yan; Chen, Qi; Liu, Feng-Qi; Sun, Xue-Yan; Liang, Mei-Ying; Liu, Yi; Jiang, Ming; Liu, Hui; Feng, Ru; Yao, Hong-Xia; Zhang, Lei; Qian, Shen-Xian; Yang, Tong-Hua; Zhang, Jing-Yu; Shen, Xu-Liang; Yang, Lin-Hua; Hu, Jian-Da; Huang, Ren-Wei; Jiang, Zhong-Xing; Wang, Jing-Wen; Zhang, Hong-Yu; Xiao, Zhen; Zhan, Si-Yan; Liu, Hui-Xin; Chang, Ying-Jun; Jiang, Qian; Jiang, Hao; Lu, Jin; Xu, Lan-Ping; Zhang, Xiao-Hong; Yin, Cheng-Hong; Wang, Jian-Liu; Huang, Xiao-Jun; Zhang, Xiao-Hui.
Affiliation
  • Huang QS; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Zhu XL; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Qu QY; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Liu X; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Zhang GC; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Su Y; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Chen Q; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Liu FQ; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Sun XY; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Liang MY; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Liu Y; Department of Hematology, Navy General Hospital, Beijing, China.
  • Jiang M; Center of Hematologic Diseases, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Liu H; Department of Hematology, Beijing Hospital, Beijing, China.
  • Feng R; Department of Hematology, Beijing Hospital, Beijing, China.
  • Yao HX; Department of Hematology, People's Hospital of Hainan Province, Haikou, China.
  • Zhang L; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Qian SX; Department of Hematology, First People's Hospital of Hangzhou, Hangzhou, China.
  • Yang TH; Department of Hematology, First People's Hospital of Yunnan Province, Kunming, China.
  • Zhang JY; Department of Hematology, Hebei Institute of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Shen XL; Department of Hematology, He Ping Central Hospital of the Changzhi Medical College, Changzhi, China.
  • Yang LH; Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Hu JD; Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Huang RW; Department of Hematology, Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
  • Jiang ZX; Department of Hematology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang JW; Department of Hematology, Beijing Tongren Hospital, Beijing, China.
  • Zhang HY; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Xiao Z; Department of Hematology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • Zhan SY; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
  • Liu HX; Department of Clinical Epidemiology, Peking University People's Hospital, Beijing, China.
  • Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang H; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Lu J; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Xu LP; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Zhang XH; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Yin CH; Department of Internal Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
  • Wang JL; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology; National Clinical Research Center for Hematologic Disease; Collaborative Innovation Center of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Am J Hematol ; 96(5): 561-570, 2021 05 01.
Article in En | MEDLINE | ID: mdl-33606900

Full text: 1 Database: MEDLINE Main subject: Pregnancy Complications, Hematologic / Purpura, Thrombocytopenic, Idiopathic / Postpartum Hemorrhage Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Newborn / Pregnancy Country/Region as subject: Asia Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pregnancy Complications, Hematologic / Purpura, Thrombocytopenic, Idiopathic / Postpartum Hemorrhage Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Newborn / Pregnancy Country/Region as subject: Asia Language: En Year: 2021 Type: Article